Testing effectiveness (Phase 2)Study completedNCT00494585What this trial is testingCEP-701 for PH-negative MyelofibrosisWho this might be right forLeukemiaMyelofibrosis M.D. Anderson Cancer Center 27
Not applicableLooking for participantsNCT02760238What this trial is testingMyeloproliferative Neoplasms (MPNs) Patient RegistryWho this might be right forPrimary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more University Health Network, Toronto 5,000
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Not applicableStudy completedNCT01499147What this trial is testingFludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute LeukemiaChronic Myelogenous Leukemia+8 more University of Illinois at Chicago 100
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00069992What this trial is testingTotal-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes Baylor College of Medicine 7
Testing effectiveness (Phase 2)Looking for participantsNCT05805605What this trial is testingAllo HSCT Using RIC and PTCy for Hematological DiseasesWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more Masonic Cancer Center, University of Minnesota 56
Early research (Phase 1)Study completedNCT00005967What this trial is testingTipifarnib in Treating Patients With Advanced Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Cancer Institute (NCI) 36
Early research (Phase 1)Looking for participantsNCT06218628What this trial is testingPacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 InhibitionWho this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+3 more Fox Chase Cancer Center 24
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800What this trial is testingCINC424A2X01B Rollover ProtocolWho this might be right forPrimary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more Novartis Pharmaceuticals 279
Testing effectiveness (Phase 2)UnknownNCT04888741What this trial is testingMethods of T Cell Depletion Trial (MoTD)Who this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more University of Birmingham 400
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Ended earlyNCT04637009What this trial is testingTAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm Astex Pharmaceuticals, Inc. 20
Not applicableActive Not RecruitingNCT01199562What this trial is testingInfection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more City of Hope Medical Center 153
Not applicableEnded earlyNCT00900068What this trial is testingBlood Samples From Patients on a Clinical Trial to CINV During HSCTWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00309842What this trial is testingMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Study completedNCT00807677What this trial is testingDose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more Millennium Pharmaceuticals, Inc. 31